ARTICLE | Clinical News
Neurex regulatory update
July 1, 1996 7:00 AM UTC
NXCO filed an NDA for Corlopam (fenoldopam mesylate) for intravenous use in patients who require blood pressure control during and after surgery, as well as hypertensive patients for whom oral medica...